MolNFT v1 · #139304 · protein
Lanthanoid tagging via an unnatural amino acid for protein structure characterization
5XBO · Polyubiquitin-B: “Lanthanoid tagging via an unnatural amino acid for protein structure characterization”. Solution nmr, 1 ligand (TB). MolNFT v1 #139304 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 5XBO
- Type
- protein
- Length
- 125 residues
- Chains
- 2
- Method
- solution nmr
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Polyubiquitin-B; UV excision repair protein RAD23 homolog a
- UniProt
- P0CG47, P54725
- Ligands
- TB
Structure
solution nmr · 2 distinct chains · 40% helix, 21% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Polyubiquitin-B | protein | 76 | 24% helix, 34% strand | P0CG47 |
| B | UV excision repair protein RAD23 homolog a | protein | 49 | 65% helix, 0% strand | P54725 |
Ligands and binding sites
- TB · Terbium(iii) ion · metal
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Interfaces
1 interface between chains.
- A–B · 356 Ų buried · 0 hydrogen bonds · protein-protein
Compared structures
- 5XBO · Lanthanoid tagging via an unnatural amino acid for protein structure characterization · the same entry in another collection · chain A against A, TM-score 1.00
- P54725 · AlphaFold monomer V2.0 prediction for UV excision repair protein RAD23 homolog a (P54725) · a predicted model of the same protein · chain B against A, TM-score 0.75
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P0CG47
- Every structure of UniProt P54725
- Elsewhere: RCSB PDB 5XBO · PDBe 5XBO · UniProt P0CG47 · UniProt P54725
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.